2009
DOI: 10.1016/j.neurobiolaging.2007.11.017
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid-β precursor protein mediates neuronal toxicity of amyloid β through Go protein activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
55
1
1

Year Published

2009
2009
2020
2020

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 39 publications
(61 citation statements)
references
References 51 publications
4
55
1
1
Order By: Relevance
“…Furthermore, the G␣ o subunit has been shown to be involved in Alzheimer's disease, in which the amyloid precursor protein mediates the neuronal toxicity of A␤ oligomers through G␣ o activation (67). It would be interesting to evaluate how these elements interact and how FZD9 is involved in these processes.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the G␣ o subunit has been shown to be involved in Alzheimer's disease, in which the amyloid precursor protein mediates the neuronal toxicity of A␤ oligomers through G␣ o activation (67). It would be interesting to evaluate how these elements interact and how FZD9 is involved in these processes.…”
Section: Discussionmentioning
confidence: 99%
“…sAPP has been reported to have many neuroprotective and neurotrophic functions within the central nervous system (CNS) (Mattson et al, 1993); for instance, sAPP administration reduced neuronal injury and improved functional outcome following rat TBI (Thornton et al, 2006). The -secretase pathway is a non-amyloidogenic pathway in which the majority of APP is normally processed (Suh and Checler 2002), while after brain injury the -and -secretase pathways are activated and are responsible for producing the toxic sAPP (Matrone et al, 2008;Sola Vigo et al, 2008) and A (Mills and www.intechopen.com Reiner 1999; Stone et al, 2002;Blasko et al, 2004). For instance, sAPP was shown to induce apoptotic cell death in PC 12 cells and neuronal degeneration in rat hippocampal neurons (Matrone et al, 2008;Sola Vigo et al, 2008).…”
Section: Discussionmentioning
confidence: 99%
“…The -secretase pathway is a non-amyloidogenic pathway in which the majority of APP is normally processed (Suh and Checler 2002), while after brain injury the -and -secretase pathways are activated and are responsible for producing the toxic sAPP (Matrone et al, 2008;Sola Vigo et al, 2008) and A (Mills and www.intechopen.com Reiner 1999; Stone et al, 2002;Blasko et al, 2004). For instance, sAPP was shown to induce apoptotic cell death in PC 12 cells and neuronal degeneration in rat hippocampal neurons (Matrone et al, 2008;Sola Vigo et al, 2008). Nakagawa et al reported that the APP overexpression of ST6Gal-1 in Neuro2 enhanced producing sAPP and the level of the extracellular sAPP form is increased the level of sAPP form (Nakagawa et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…A␤ can induce APP oligomerization and caspase cleavage at Asp 664 , liberating an APP fragment containing the C-terminal 31 amino acids (52,53). This APP C-terminal fragment is neurotoxic when overexpressed (54) and may activate a G-protein signaling cascade (55).…”
Section: A␤-app Interactions and Toxicitymentioning
confidence: 99%